| scholarly article | Q13442814 |
| P50 | author | Carissa M Thomas | Q91504612 |
| P2093 | author name string | James Versalovic | |
| P2860 | cites work | Development of the human infant intestinal microbiota | Q21003936 |
| Almost all irritable bowel syndromes are post-infectious and respond to probiotics: controversial issues | Q51738716 | ||
| Lymphoid tissue genesis induced by commensals through NOD1 regulates intestinal homeostasis | Q52590127 | ||
| The probiotic Escherichia coli strain Nissle 1917 induces gammadelta T cell apoptosis via caspase- and FasL-dependent pathways | Q52918725 | ||
| Bioproduction of conjugated linoleic acid by probiotic bacteria occurs in vitro and in vivo in mice | Q53622713 | ||
| Studies of intestinal microflora. II. Microorganisms of the small intestine and their relations to oral and fecal flora | Q53860780 | ||
| Gene expression profiling of chicken lymphoid cells after treatment with Lactobacillus acidophilus cellular components. | Q54235496 | ||
| Lactic acid bacteria differ in their ability to induce functional regulatory T cells in humans | Q54397300 | ||
| Modulation of apoptosis in intestinal lymphocytes by a probiotic bacteria in Crohn's disease | Q54466275 | ||
| Probiotic lactobacilli and VSL#3 induce enterocyte beta-defensin 2. | Q54551350 | ||
| Postinfectious irritable bowel syndrome | Q56991065 | ||
| Intestinal Bacteria Trigger T Cell-Independent Immunoglobulin A2 Class Switching by Inducing Epithelial-Cell Secretion of the Cytokine APRIL | Q58493951 | ||
| Growth phase of orally administered Lactobacillus strains differentially affects IgG1/IgG2a ratio for soluble antigens: implications for vaccine development | Q73506984 | ||
| Lactobacilli and Streptococci activate NF-kappa B and STAT signaling pathways in human macrophages | Q73567345 | ||
| A primitive T cell-independent mechanism of intestinal mucosal IgA responses to commensal bacteria | Q73919528 | ||
| Lactobacilli Differentially Modulate Expression of Cytokines and Maturation Surface Markers in Murine Dendritic Cells | Q77373909 | ||
| Probiotics and prebiotic galacto-oligosaccharides in the prevention of allergic diseases: a randomized, double-blind, placebo-controlled trial | Q79510185 | ||
| IgA response to symbiotic bacteria as a mediator of gut homeostasis | Q79841107 | ||
| Effect of long-term continuous consumption of fermented milk containing probiotic bacteria on mucosal immunity and the activity of peritoneal macrophages | Q80610913 | ||
| Probiotics modulate inflammatory cytokine secretion from inflamed mucosa in active ulcerative colitis | Q82632663 | ||
| Saccharomyces boulardii produces a soluble anti-inflammatory factor that inhibits NF-kappaB-mediated IL-8 gene expression | Q82789415 | ||
| Effects of Lactobacillus plant arum on genes expression pattern in mice jejunal Peyer's patches | Q83737769 | ||
| Gut commensal Lactobacillus reuteri 100-23 stimulates an immunoregulatory response | Q84592910 | ||
| Probiotics inhibit nuclear factor-kappaB and induce heat shock proteins in colonic epithelial cells through proteasome inhibition | Q45134589 | ||
| Probiotics ameliorate recurrent Th1-mediated murine colitis by inducing IL-10 and IL-10-dependent TGF-beta-bearing regulatory cells | Q45304815 | ||
| Effect of Lactobacillus gasseri BNR17 on blood glucose levels and body weight in a mouse model of type 2 diabetes. | Q46003889 | ||
| Effects of Lactobacillus GG on genes expression pattern in small bowel mucosa | Q46447757 | ||
| Balancing inflammatory, lipid, and xenobiotic signaling pathways by VSL#3, a biotherapeutic agent, in the treatment of inflammatory bowel disease | Q46495260 | ||
| Suppression of histamine signaling by probiotic Lac-B: a possible mechanism of its anti-allergic effect | Q46547160 | ||
| Probiotics may reduce inflammation by enhancing peroxisome proliferator activated receptor gamma activation in HT-29 cells | Q46825426 | ||
| DNA from probiotic bacteria modulates murine and human epithelial and immune function | Q47635337 | ||
| Effect of a probiotic formula on intestinal immunoglobulin A production in healthy children | Q47677013 | ||
| Impaired expression of peroxisome proliferator-activated receptor gamma in ulcerative colitis | Q47933212 | ||
| Toll-like receptor 2 and nucleotide-binding oligomerization domain-2 play divergent roles in the recognition of gut-derived lactobacilli and bifidobacteria in dendritic cells | Q47961731 | ||
| Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria | Q47962035 | ||
| Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-gamma and RelA. | Q50101913 | ||
| Prokaryotic regulation of epithelial responses by inhibition of IkappaB-alpha ubiquitination | Q50119689 | ||
| Mechanisms of Disease: pathogenesis of Crohn's disease and ulcerative colitis | Q22251072 | ||
| Commensal bacteria modulate cullin-dependent signaling via generation of reactive oxygen species | Q24296438 | ||
| The Bacillus subtilis quorum-sensing molecule CSF contributes to intestinal homeostasis via OCTN2, a host cell membrane transporter | Q24300533 | ||
| Diversity of the human intestinal microbial flora | Q24544241 | ||
| Saccharomyces boulardii protease inhibits the effects of Clostridium difficile toxins A and B in human colonic mucosa | Q24548845 | ||
| Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine | Q24648636 | ||
| Host-bacterial mutualism in the human intestine | Q27861037 | ||
| Induction of intestinal Th17 cells by segmented filamentous bacteria | Q28131638 | ||
| Butyrate inhibits inflammatory responses through NFkappaB inhibition: implications for Crohn's disease | Q28143405 | ||
| Commensal host-bacterial relationships in the gut | Q28188763 | ||
| Encapsulated Bifidobacterium bifidum potentiates intestinal IgA production | Q28216965 | ||
| Ecological and evolutionary forces shaping microbial diversity in the human intestine | Q29547586 | ||
| Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients | Q29614261 | ||
| A microbial symbiosis factor prevents intestinal inflammatory disease | Q29614263 | ||
| An ecological and evolutionary perspective on human-microbe mutualism and disease | Q29614265 | ||
| An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system | Q29614267 | ||
| Interactions between commensal intestinal bacteria and the immune system | Q29617039 | ||
| A key role of dendritic cells in probiotic functionality | Q30830505 | ||
| Supernatant from bifidobacterium differentially modulates transduction signaling pathways for biological functions of human dendritic cells | Q33354056 | ||
| Comparison of the immunomodulatory properties of three probiotic strains of Lactobacilli using complex culture systems: prediction for in vivo efficacy | Q33503647 | ||
| Probiotic bacterium prevents cytokine-induced apoptosis in intestinal epithelial cells | Q33554139 | ||
| Generation of regulatory dendritic cells and CD4+Foxp3+ T cells by probiotics administration suppresses immune disorders | Q33719638 | ||
| Probiotic Lactobacillus spp. diminish Helicobacter hepaticus-induced inflammatory bowel disease in interleukin-10-deficient mice | Q33795727 | ||
| Enhanced antiinflammatory capacity of a Lactobacillus plantarum mutant synthesizing modified teichoic acids | Q33900587 | ||
| Targeting the human microbiome with antibiotics, probiotics, and prebiotics: gastroenterology enters the metagenomics era | Q33939802 | ||
| Divergent patterns of colonization and immune response elicited from two intestinal Lactobacillus strains that display similar properties in vitro | Q34522706 | ||
| Lactobacillus rhamnosus blocks inflammatory signaling in vivo via reactive oxygen species generation | Q34610586 | ||
| Lipoteichoic acids from Lactobacillus strains elicit strong tumor necrosis factor alpha-inducing activities in macrophages through Toll-like receptor 2 | Q34778968 | ||
| Saccharomyces boulardii protease inhibits Clostridium difficile toxin A effects in the rat ileum. | Q35532152 | ||
| Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn's disease: a randomised controlled trial with Lactobacillus GG. | Q35594940 | ||
| Live probiotics protect intestinal epithelial cells from the effects of infection with enteroinvasive Escherichia coli (EIEC) | Q35595770 | ||
| Dendritic-cell control of pathogen-driven T-cell polarization | Q35597117 | ||
| Immunity, inflammation, and allergy in the gut. | Q36080132 | ||
| Immune responses that adapt the intestinal mucosa to commensal intestinal bacteria | Q36122642 | ||
| Enterococcus faecalis from newborn babies regulate endogenous PPARgamma activity and IL-10 levels in colonic epithelial cells | Q36882991 | ||
| Differential NF-kappaB pathways induction by Lactobacillus plantarum in the duodenum of healthy humans correlating with immune tolerance | Q37114872 | ||
| Probiotics ameliorate the hydrogen peroxide-induced epithelial barrier disruption by a PKC- and MAP kinase-dependent mechanism | Q37122645 | ||
| Immunomodulatory effects of probiotics in the intestinal tract | Q37182262 | ||
| The probiotic Lactobacillus GG may augment intestinal host defense by regulating apoptosis and promoting cytoprotective responses in the developing murine gut | Q37223685 | ||
| Bacteria-free solution derived from Lactobacillus plantarum inhibits multiple NF-kappaB pathways and inhibits proteasome function | Q37356352 | ||
| Regulatory lymphocytes and intestinal inflammation. | Q37419380 | ||
| The role of the gut microbiota in energy metabolism and metabolic disease | Q37481953 | ||
| Live Lactobacillus rhamnosus [corrected] is essential for the inhibitory effect on tumor necrosis factor alpha-induced interleukin-8 expression | Q37521881 | ||
| How do regulatory T cells work? | Q37596517 | ||
| Saccharomyces boulardii preserves the barrier function and modulates the signal transduction pathway induced in enteropathogenic Escherichia coli-infected T84 cells | Q39536940 | ||
| Lactobacillus strains induce TRAIL production and facilitate natural killer activity against cancer cells | Q39765675 | ||
| Preferential promotion of apoptosis of monocytes by Lactobacillus casei rhamnosus soluble factors | Q39815040 | ||
| Probiotic Lactobacillus casei strain Shirota prevents indomethacin-induced small intestinal injury: involvement of lactic acid | Q39826904 | ||
| Anti-inflammatory effects of the genus Bifidobacterium on macrophages by modification of phospho-I kappaB and SOCS gene expression | Q39866028 | ||
| Lactobacillus crispatus M247-derived H2O2 acts as a signal transducing molecule activating peroxisome proliferator activated receptor-gamma in the intestinal mucosa. | Q39947912 | ||
| Inhibitory effects of Lactobacillus plantarum lipoteichoic acid (LTA) on Staphylococcus aureus LTA-induced tumor necrosis factor-alpha production. | Q39965371 | ||
| Probiotic Lactobacillus reuteri promotes TNF-induced apoptosis in human myeloid leukemia-derived cells by modulation of NF-kappaB and MAPK signalling | Q40004010 | ||
| In vitro and in vivo effects of the probiotic Escherichia coli strain M-17: immunomodulation and attenuation of murine colitis | Q40012607 | ||
| Lipoteichoic acid isolated from Lactobacillus plantarum inhibits lipopolysaccharide-induced TNF-alpha production in THP-1 cells and endotoxin shock in mice | Q40016384 | ||
| NF-kappaB- and AP-1-mediated induction of human beta defensin-2 in intestinal epithelial cells by Escherichia coli Nissle 1917: a novel effect of a probiotic bacterium. | Q40017434 | ||
| Probiotic Lactobacillus reuteri suppress proinflammatory cytokines via c-Jun | Q40100857 | ||
| Molecular mechanisms underlying the probiotic effects of Escherichia coli Nissle 1917 involve ZO-2 and PKCzeta redistribution resulting in tight junction and epithelial barrier repair | Q40211588 | ||
| G-CSF-mediated inhibition of JNK is a key mechanism for Lactobacillus rhamnosus-induced suppression of TNF production in macrophages | Q40247336 | ||
| Saccharomyces boulardii inhibits ERK1/2 mitogen-activated protein kinase activation both in vitro and in vivo and protects against Clostridium difficile toxin A-induced enteritis | Q40260363 | ||
| Probiotics and commensals reverse TNF-alpha- and IFN-gamma-induced dysfunction in human intestinal epithelial cells | Q40306324 | ||
| Supernatant of Bifidobacterium breve induces dendritic cell maturation, activation, and survival through a Toll-like receptor 2 pathway | Q40307811 | ||
| Anti-inflammatory effect of Lactobacillus casei on Shigella-infected human intestinal epithelial cells | Q40333778 | ||
| Soluble factors from Lactobacillus GG activate MAPKs and induce cytoprotective heat shock proteins in intestinal epithelial cells | Q40348113 | ||
| Innate mechanisms for Bifidobacterium lactis to activate transient pro-inflammatory host responses in intestinal epithelial cells after the colonization of germ-free rats. | Q40398677 | ||
| Alive and dead Lactobacillus rhamnosus GG decrease tumor necrosis factor-alpha-induced interleukin-8 production in Caco-2 cells | Q40403481 | ||
| Lactic acid bacteria secrete metabolites retaining anti-inflammatory properties after intestinal transport | Q40557124 | ||
| Functional modulation of enterocytes by gram-positive and gram-negative microorganisms | Q40580514 | ||
| IKK beta and phosphatidylinositol 3-kinase/Akt participate in non-pathogenic Gram-negative enteric bacteria-induced RelA phosphorylation and NF-kappa B activation in both primary and intestinal epithelial cell lines | Q40715411 | ||
| A three-tiered view of the role of IgA in mucosal defense | Q40769594 | ||
| High-level expression of I kappa B-beta in the surface epithelium of the colon: in vitro evidence for an immunomodulatory role | Q40909466 | ||
| Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression. | Q40961532 | ||
| Lactobacilli and vaginal host defense: activation of the human immunodeficiency virus type 1 long terminal repeat, cytokine production, and NF-kappaB. | Q40974372 | ||
| Lactobacillus fermentum attenuates the proinflammatory effect of Yersinia enterocolitica on human epithelial cells. | Q41450612 | ||
| Soluble proteins produced by probiotic bacteria regulate intestinal epithelial cell survival and growth | Q41863620 | ||
| Probiotics inhibit TNF-alpha-induced interleukin-8 secretion of HT29 cells. | Q41975206 | ||
| Extracellular MUC3 mucin secretion follows adherence of Lactobacillus strains to intestinal epithelial cells in vitro | Q42282244 | ||
| Escherichia coli Nissle 1917 distinctively modulates T-cell cycling and expansion via toll-like receptor 2 signaling | Q42704864 | ||
| Modulation of human dendritic cell phenotype and function by probiotic bacteria | Q43004747 | ||
| Commensal bacteria trigger a full dendritic cell maturation program that promotes the expansion of non-Tr1 suppressor T cells. | Q44082495 | ||
| Prevention of TNBS-induced colitis by different Lactobacillus and Bifidobacterium strains is associated with an expansion of gammadeltaT and regulatory T cells of intestinal intraepithelial lymphocytes | Q44414008 | ||
| Enteric flora and lymphocyte-derived cytokines determine expression of heat shock proteins in mouse colonic epithelial cells | Q44429814 | ||
| P433 | issue | 3 | |
| P921 | main subject | probiotics | Q1816730 |
| P304 | page(s) | 148-163 | |
| P577 | publication date | 2010-05-01 | |
| P13046 | publication type of scholarly work | review article | Q7318358 |
| P1433 | published in | Gut microbes | Q26841922 |
| P1476 | title | Probiotics-host communication: Modulation of signaling pathways in the intestine | |
| P478 | volume | 1 |
| Q39031458 | A co-culture model of the developing small intestine offers new insight in the early immunomodulation of enterocytes and macrophages by Lactobacillus spp. through STAT1 and NF-kB p65 translocation. |
| Q36975121 | A prospective, randomized, blinded, placebo-controlled pilot study on the effect of Enterococcus faecium on clinical activity and intestinal gene expression in canine food-responsive chronic enteropathy. |
| Q92151484 | A randomized double-blind placebo-controlled trial of probiotics in post-surgical colorectal cancer |
| Q47159439 | Adjuvant Probiotics and the Intestinal Microbiome: Enhancing Vaccines and Immunotherapy Outcomes |
| Q90267631 | Administration of a Synbiotic Containing Enterococcus faecium Does Not Significantly Alter Fecal Microbiota Richness or Diversity in Dogs With and Without Food-Responsive Chronic Enteropathy |
| Q88588840 | Age-related changes in the gut microbiota influence systemic inflammation and stroke outcome |
| Q37911576 | An intimate tête-à-tête — How probiotic lactobacilli communicate with the host |
| Q39123607 | Anti-obesity effect of Lactobacillus gasseri SBT2055 accompanied by inhibition of pro-inflammatory gene expression in the visceral adipose tissue in diet-induced obese mice |
| Q58777471 | Aspects of Gut Microbiota and Immune System Interactions in Infectious Diseases, Immunopathology, and Cancer |
| Q42324273 | Bacillus subtilis biofilm extends Caenorhabditis elegans longevity through downregulation of the insulin-like signalling pathway |
| Q92160367 | Beneficial effects of dietary supplementation of Bacillus strains on growth performance and gut health in chickens with mixed coccidiosis infection |
| Q36155996 | Caenorhabditis elegans Immune Conditioning with the Probiotic Bacterium Lactobacillus acidophilus Strain NCFM Enhances Gram-Positive Immune Responses |
| Q53267181 | Cell-Free Supernatants from ProbioticLactobacillus caseiandLactobacillus rhamnosusGG Decrease Colon Cancer Cell Invasion In Vitro |
| Q34983614 | Chronic HIV infection enhances the responsiveness of antigen presenting cells to commensal Lactobacillus |
| Q91613852 | Combination of Lactobacillus acidophilus and Bifidobacterium animalis subsp. lactis Shows a Stronger Anti-Inflammatory Effect than Individual Strains in HT-29 Cells |
| Q38205034 | Cross-talk between probiotic lactobacilli and host immune system |
| Q35577828 | Cyclopropane fatty acid synthase mutants of probiotic human-derived Lactobacillus reuteri are defective in TNF inhibition |
| Q35118425 | Diet effects in gut microbiome and obesity. |
| Q51000827 | Dietary Bacillus subtilis-based direct-fed microbials alleviate LPS-induced intestinal immunological stress and improve intestinal barrier gene expression in commercial broiler chickens |
| Q50596657 | Dietary calcium concentration and cereals differentially affect mineral balance and tight junction proteins expression in jejunum of weaned pigs |
| Q64284787 | Dietary probiotics have different effects on the composition of fecal microbiota in farmed raccoon dog (Nyctereutes procyonoides) and silver fox (Vulpes vulpes fulva) |
| Q34039831 | Duodenal and faecal microbiota of celiac children: molecular, phenotype and metabolome characterization |
| Q36122235 | Effect of probiotics and synbiotics on blood glucose: a systematic review and meta-analysis of controlled trials. |
| Q43849697 | Effects of dietary supplementation of Bacillus amyloliquefaciens CECT 5940 and Enterococcus faecium CECT 4515 in adult healthy dogs. |
| Q47810617 | Effects of oral Lactobacillus administration on antioxidant activities and CD4+CD25+forkhead box P3 (FoxP3)+ T cells in NZB/W F1 mice |
| Q36515602 | Effects of probiotics on gut microbiota: mechanisms of intestinal immunomodulation and neuromodulation |
| Q89287303 | Effects of the Dietary Probiotic, Enterococcus faecium NCIMB11181, on the Intestinal Barrier and System Immune Status in Escherichia coli O78-Challenged Broiler Chickens |
| Q64882730 | Egg Production in Poultry Farming Is Improved by Probiotic Bacteria. |
| Q34057126 | Epithelial adhesion mediated by pilin SpaC is required for Lactobacillus rhamnosus GG-induced cellular responses. |
| Q34632100 | Evaluation of the immune benefits of two probiotic strains Bifidobacterium animalis ssp. lactis, BB-12® and Lactobacillus paracasei ssp. paracasei, L. casei 431® in an influenza vaccination model: a randomised, double-blind, placebo-controlled study |
| Q28740609 | Exploring metabolic pathway reconstruction and genome-wide expression profiling in Lactobacillus reuteri to define functional probiotic features |
| Q38108088 | Feeding the immune system |
| Q42586904 | Five probiotic drops a day to keep infantile colic away? |
| Q37334837 | FolC2-mediated folate metabolism contributes to suppression of inflammation by probiotic Lactobacillus reuteri |
| Q37505077 | Fructooligosacharides reduce Pseudomonas aeruginosa PAO1 pathogenicity through distinct mechanisms |
| Q110693640 | Genome analysis of probiotic bacteria for antibiotic resistance genes |
| Q36252576 | Genome-Wide Immune Modulation of TLR3-Mediated Inflammation in Intestinal Epithelial Cells Differs between Single and Multi-Strain Probiotic Combination |
| Q28238138 | Gut bacteria in health and disease |
| Q40801146 | Gut-Colonizing Bacteria Promote C. elegans Innate Immunity by Producing Nitric Oxide |
| Q64969076 | Health Benefits of Heat-Killed (Tyndallized) Probiotics: An Overview. |
| Q28481171 | Histamine derived from probiotic Lactobacillus reuteri suppresses TNF via modulation of PKA and ERK signaling |
| Q26852306 | Host modulation therapy: An indispensable part of perioceutics |
| Q35981844 | Host-Microbiome Cross-talk in Oral Mucositis |
| Q92517352 | How the gut microbiome regulates host immune responses to viral vaccines |
| Q33777194 | Identification of Lactobacillus strains with probiotic features from the bottlenose dolphin (Tursiops truncatus) |
| Q36670816 | Immunomodulation of Lactobacillus rhamnosus GG (LGG)-derived soluble factors on antigen-presenting cells of healthy blood donors |
| Q38946397 | Immunomodulation of monocytes by probiotic and selected lactic Acid bacteria |
| Q42370473 | Impact of supplementation with a food-derived microbial community on obesity-associated inflammation and gut microbiota composition |
| Q35546593 | Intravaginal lactic Acid bacteria modulated local and systemic immune responses and lowered the incidence of uterine infections in periparturient dairy cows |
| Q35161373 | Irritable bowel syndrome, gut microbiota and probiotics. |
| Q35758846 | Is lactate an undervalued functional component of fermented food products? |
| Q64118992 | KLDS1.0318 Ameliorates Impaired Intestinal Immunity and Metabolic Disorders in Cyclophosphamide-Treated Mice |
| Q61449169 | Lactobacillus Dominate in the Intestine of Atlantic Salmon Fed Dietary Probiotics |
| Q50041293 | Lactobacillus S-layer protein inhibition of Salmonella-induced reorganization of the cytoskeleton and activation of MAPK signalling pathways in Caco-2 cells |
| Q46539797 | Lactobacillus crispatus strain SJ-3C-US induces human dendritic cells (DCs) maturation and confers an anti-inflammatory phenotype to DCs. |
| Q64994748 | Lactobacillus helveticus (ATCC 27558) upregulates Runx2 and Bmp2 and modulates bone mineral density in ovariectomy-induced bone loss rats. |
| Q39760916 | Lactobacillus johnsonii N6.2 Stimulates the Innate Immune Response through Toll-Like Receptor 9 in Caco-2 Cells and Increases Intestinal Crypt Paneth Cell Number in BioBreeding Diabetes-Prone Rats |
| Q41923219 | Lipoteichoic Acid of Probiotic Lactobacillus plantarum Attenuates Poly I:C-Induced IL-8 Production in Porcine Intestinal Epithelial Cells |
| Q37499814 | Local and systemic immune mechanisms underlying the anti-colitis effects of the dairy bacterium Lactobacillus delbrueckii |
| Q26776185 | Luminal Conversion and Immunoregulation by Probiotics |
| Q21562212 | Lysate of probiotic Lactobacillus casei DN-114 001 ameliorates colitis by strengthening the gut barrier function and changing the gut microenvironment |
| Q27012999 | Mechanisms and therapeutic effectiveness of lactobacilli |
| Q28077783 | Metabiotics: One Step ahead of Probiotics; an Insight into Mechanisms Involved in Anticancerous Effect in Colorectal Cancer |
| Q34960559 | Microbiota in health and irritable bowel syndrome: current knowledge, perspectives and therapeutic options. |
| Q55025271 | Microbiota modification by probiotic supplementation reduces colitis associated colon cancer in mice. |
| Q33958897 | Microbiota-host interactions in irritable bowel syndrome: epithelial barrier, immune regulation and brain-gut interactions |
| Q58620615 | Mitigation of Foodborne Illnesses by Probiotics |
| Q38030588 | Modulation of vaccine response by concomitant probiotic administration |
| Q37643234 | Multistrain probiotic modulation of intestinal epithelial cells' immune response to a double-stranded RNA ligand, poly(i·c). |
| Q61448103 | Nutritional Modulation of Immune Function: Analysis of Evidence, Mechanisms, and Clinical Relevance |
| Q36637753 | Nutritional modulators of ulcerative colitis: clinical efficacies and mechanistic view |
| Q48096334 | Open-label pilot for treatment targeting gut dysbiosis in myalgic encephalomyelitis/chronic fatigue syndrome: neuropsychological symptoms and sex comparisons. |
| Q90228845 | Postbiotics and Their Potential Applications in Early Life Nutrition and Beyond |
| Q38327610 | Prevention of functional gastrointestinal disorders in neonates: clinical and socioeconomic impact. |
| Q53687965 | Probiotic Supplementation in Morbid Obese Patients Undergoing One Anastomosis Gastric Bypass-Mini Gastric Bypass (OAGB-MGB) Surgery: a Randomized, Double-Blind, Placebo-Controlled, Clinical Trial |
| Q38759239 | Probiotic activity of Enterococcus faecalis CECT7121: effects on mucosal immunity and intestinal epithelial cells |
| Q30248234 | Probiotic supplementation in children with cystic fibrosis-a systematic review |
| Q27021831 | Probiotic use in horses - what is the evidence for their clinical efficacy? |
| Q57141422 | Probiotics in Disease Prevention and Treatment |
| Q82416873 | Probiotics in Gastrointestinal Disorders |
| Q35923837 | Probiotics, antibiotics and the immune responses to vaccines. |
| Q30425561 | Probiotics, enteric and diarrheal diseases, and global health. |
| Q104459094 | Receptor-targeted engineered probiotics mitigate lethal Listeria infection |
| Q34325642 | Restoring specific lactobacilli levels decreases inflammation and muscle atrophy markers in an acute leukemia mouse model |
| Q59132180 | Reversing the immune ageing clock: lifestyle modifications and pharmacological interventions |
| Q41626648 | Secretome of Intestinal Bacilli: A Natural Guard against Pathologies |
| Q35165968 | Stimulation of duodenal biopsies and whole blood from dogs with food-responsive chronic enteropathy and healthy dogs with Toll-like receptor ligands and probiotic Enterococcus faecium |
| Q89014314 | Supplementation of p40, a Lactobacillus rhamnosus GG-derived protein, in early life promotes epidermal growth factor receptor-dependent intestinal development and long-term health outcomes |
| Q59806723 | Suppression of Intestinal Epithelial Cell Chemokine Production by R0011 and R0389 Is Mediated by Secreted Bioactive Molecules |
| Q36063476 | Synergistic effects of probiotic Leuconostoc mesenteroides and Bacillus subtilis in malted ragi (Eleucine corocana) food for antagonistic activity against V. cholerae and other beneficial properties |
| Q64249465 | Systematic Review of Gut Microbiota and Major Depression |
| Q55378561 | The Anti-inflammatory Effects of Glycerol-supplemented Probiotic Lactobacillus reuteri on Infected Epithelial cells In vitro. |
| Q40227869 | The Effect of Lactobacillus acidophilus PTCC 1643 on Cultured Intestinal Epithelial Cells Infected with Salmonella enterica serovar Enteritidis. |
| Q35880704 | The Effect of Lactobacillus casei 32G on the Mouse Cecum Microbiota and Innate Immune Response Is Dose and Time Dependent |
| Q65000095 | The Effect of Orally Administered Probiotics on the Behavioral, Cellular, and Molecular Aspects of Adjuvant-Induced Arthritis. |
| Q51049970 | The Effects of Direct-fed Microbial Supplementation, as an Alternative to Antibiotics, on Growth Performance, Intestinal Immune Status, and Epithelial Barrier Gene Expression in Broiler Chickens |
| Q90454567 | The Gut Microbiome as a Major Regulator of the Gut-Skin Axis |
| Q51663001 | The design of probiotic studies to substantiate health claims |
| Q41529290 | The effect of probiotics on serum levels of cytokine and endotoxin in peritoneal dialysis patients: a randomised, double-blind, placebo-controlled trial |
| Q50099393 | The effects of combined probiotic ingestion and circuit training on muscular strength and power and cytokine responses in young males |
| Q51326452 | The effects of probiotic bacteria on glycaemic control in overweight men and women: a randomised controlled trial |
| Q91806621 | The pros, cons, and many unknowns of probiotics |
| Q35874114 | The role of nutrition in enhancing immunity in aging |
| Q48127523 | Transcriptional regulation of adhesive properties of Bacillus subtilis to extracellular matrix proteins through the fibronectin-binding protein YloA. |
| Q42657761 | Understanding the canine intestinal microbiota and its modification by pro-, pre- and synbiotics - what is the evidence? |
| Q30832085 | Visualization of Probiotic-Mediated Ca2+ Signaling in Intestinal Epithelial Cells In Vivo |
Search more.